|
LV Intracox Oral
|
25 mg/ml
|
V/NRP/11/0067
|
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
QP51AJ01
|
turkeys; chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for oral use
|
| International name (active substance): |
Toltrazuril
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
| Date of authorisation/renewal: |
30-Nov-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 23012023LI (23-Jan-2023)
|
| Labelling text: |
[DOCX] 23012023M (23-Jan-2023)
|
| Summary of product characteristics: |
[DOCX] 23012023ZA (23-Jan-2023)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/11/0067-01 |
25 mg/ml |
1 |
ABPE pudele, 1000 ml |
-
|
| V/NRP/11/0067-02 |
25 mg/ml |
1 |
ABPE pudele, 100 ml |
-
|
| V/NRP/11/0067-03 |
25 mg/ml |
1 |
ABPE pudele, 500 ml |
-
|
|
|
Calci-kel 300
|
-
|
V/NRP/00/1229
|
Kela Laboratoria NV, Beļģija
|
QA12AX
|
cattle; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/00/1229-01 |
|
1 |
Polipropilēna pudele, 500 ml |
-
|
|
|
Feligen CRP
|
-
|
V/NRP/08/1606
|
Virbac S.A., Francija
|
QI06AD04
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live feline calicivirus, strain F9,Live rhinotracheitis virus F2 strain,Live Panleucopenia virus LR72 strain
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija
|
| Date of authorisation/renewal: |
30-May-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (29-Jul-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (29-Jul-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (29-Jul-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/08/1606-01 |
|
50 |
Stikla flakons, 1 deva |
-
|
| V/NRP/08/1606-02 |
|
10 |
Stikla flakons, 1 deva |
-
|
|
|
Apiguard
|
250 mg/g
|
V/NRP/03/1594
|
Vita Bee Health Limited, Īrija
|
QP53AX22
|
bees
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/03/1594-01 |
250 mg/g |
10 |
Folijas paciņa, 50 g |
-
|
|
|
Calcio PH
|
-
|
V/NRP/01/1377
|
Fatro S.p.A., Itālija
|
QA12AX
|
cattle; pigs; sheep; horses; dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1377-01 |
|
1 |
Stikla flakons, 250 ml |
-
|
| V/NRP/01/1377-02 |
|
1 |
Stikla flakons, 500 ml |
-
|
|
|
Metabolase Forte
|
-
|
V/NRP/02/1494
|
Fatro S.p.A., Itālija
|
QA11JC00
|
cattle; pigs; sheep; horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/02/1494-01 |
|
1 |
Flakons, 100 ml |
-
|
| V/NRP/02/1494-02 |
|
1 |
Flakons, 250 ml |
-
|
|
|
Frontline Spray
|
2.5 mg/ml
|
V/NRP/95/0160
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QP53AX15
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
cutaneous spray, solution
|
| International name (active substance): |
Fipronil
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS., Francija
|
| Date of authorisation/renewal: |
03-Aug-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 280720LI (28-Jul-2020)
|
| Labelling text: |
[DOCX] 280720M (28-Jul-2020)
|
| Summary of product characteristics: |
[DOCX] 280720ZA (28-Jul-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/95/0160-01 |
2,5 mg/ml |
1 |
Flakons, 100 ml |
-
|
| V/NRP/95/0160-02 |
2,5 mg/ml |
1 |
Flakons, 250 ml |
-
|
| V/NRP/95/0160-03 |
2,5 mg/ml |
1 |
Flakons, 500 ml |
-
|
|
|
Decomoton
|
0.05 mg/ml
|
V/NRP/01/1293
|
Laboratorios Calier, S.A., Spānija
|
QH01BB03
|
cattle; pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1293-01 |
0,05 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
|
|
Bovilis BVD
|
-
|
V/NRP/02/1524
|
Intervet International BV, Nīderlande
|
QI02AA01
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/02/1524-02 |
|
1 |
Stikla flakons, 10 ml |
-
|
| V/NRP/02/1524-03 |
|
1 |
Stikla flakons, 20 ml |
-
|
| V/NRP/02/1524-04 |
|
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/02/1524-05 |
|
1 |
Stikla flakons, 250 ml |
-
|
| V/NRP/02/1524-06 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/02/1524-07 |
|
1 |
PET flakons, 10 ml |
-
|
| V/NRP/02/1524-08 |
|
1 |
PET flakons, 20 ml |
-
|
| V/NRP/02/1524-09 |
|
1 |
PET flakons, 50 ml |
-
|
| V/NRP/02/1524-10 |
|
1 |
PET flakons, 100 ml |
-
|
| V/NRP/02/1524-11 |
|
1 |
PET flakons, 250 ml |
-
|
|
|
Spasmipur
|
20 mg/ml
|
V/DCP/19/0017
|
VetViva Richter GmbH , Austrija
|
QA03BB01
|
cattle; pigs; sheep; horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/19/0017-01 |
|
1 |
Stikla flakons, 50 ml |
-
|
|
|
Menbutil
|
100 mg/ml
|
V/DCP/18/0062
|
aniMedica GmbH, Vācija
|
QA05AX90
|
cattle; pigs; sheep; goats; horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0062-01 |
100 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/18/0062-02 |
100 mg/ml |
12 |
Stikla flakons, 100 ml |
-
|
|
|
Fipron
|
67 mg
|
V/MRP/16/0021
|
Bioveta, a.s., Čehija
|
QP53AX15
|
small dogs
|
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Fipronil
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
01-Feb-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] 300117LI (01-Feb-2017)
|
| Labelling text: |
[PDF] 300117M (01-Feb-2017)
|
| Summary of product characteristics: |
[PDF] 300117ZA (01-Feb-2017)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/16/0021-01 |
67 mg/deva |
1 |
Polietilēna tūbiņa, 1 deva |
-
|
| V/MRP/16/0021-02 |
67 mg/deva |
3 |
Polietilēna tūbiņa, 1 deva |
-
|
| V/MRP/16/0021-03 |
67 mg/deva |
25 |
Polietilēna tūbiņa, 1 deva |
-
|
|
|
Fipron
|
134 mg
|
V/MRP/16/0022
|
Bioveta, a.s., Čehija
|
QP53AX15
|
medium dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Fipronil
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
01-Feb-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] 300117LI (01-Feb-2017)
|
| Labelling text: |
[PDF] 300117M (01-Feb-2017)
|
| Summary of product characteristics: |
[PDF] 300117ZA (01-Feb-2017)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/16/0022-01 |
134 mg/deva |
1 |
Polietilēna tūbiņa, 1 deva |
-
|
| V/MRP/16/0022-02 |
134 mg/deva |
3 |
Polietilēna tūbiņa, 1 deva |
-
|
| V/MRP/16/0022-03 |
134 mg/deva |
25 |
Polietilēna tūbiņa, 1 deva |
-
|
|
|
Thoro VAX vet.
|
-
|
V/MRP/05/1662
|
Intervet International B.V., Nīderlande
|
QI09AB13
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Mycoplasma hyopneumoniae
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Burgwedel Biotech GmbH, Vācija
|
| Date of authorisation/renewal: |
23-Aug-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOC] 280324LI (28-Mar-2024)
|
| Labelling text: |
[PDF] 191214M (22-Dec-2014)
|
| Summary of product characteristics: |
[DOCX] 191214ZA (22-Dec-2014)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/05/1662-01 |
|
1 |
Polietilēna pudele, 50 deva |
-
|
| V/MRP/05/1662-02 |
|
2 |
Polietilēna pudele, 50 deva |
-
|
| V/MRP/05/1662-03 |
|
5 |
Polietilēna pudele, 50 deva |
-
|
| V/MRP/05/1662-04 |
|
10 |
Polietilēna pudele, 50 deva |
-
|
| V/MRP/05/1662-05 |
|
1 |
Polietilēna pudele, 100 deva |
-
|
| V/MRP/05/1662-06 |
|
2 |
Polietilēna pudele, 100 deva |
-
|
| V/MRP/05/1662-07 |
|
5 |
Polietilēna pudele, 100 deva |
-
|
| V/MRP/05/1662-08 |
|
10 |
Polietilēna pudele, 100 deva |
-
|
| V/MRP/05/1662-09 |
|
1 |
Polietilēna pudele, 200 deva |
-
|
| V/MRP/05/1662-10 |
|
2 |
Polietilēna pudele, 200 deva |
-
|
| V/MRP/05/1662-11 |
|
5 |
Polietilēna pudele, 200 deva |
-
|
| V/MRP/05/1662-12 |
|
10 |
Polietilēna pudele, 200 deva |
-
|
|
|
Canigen DHPPi/L
|
-
|
V/MRP/15/0057
|
VIRBAC, Francija
|
QI07AI02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and suspension for suspension for injection
|
| International name (active substance): |
Canine distemper virus, Lederle strain, Canine parvovirus, C.P.V.780916 strain, Canine parainfluenza virus, Manhattan strain, Live attenuated Canine Adenovirus type 2 (CAV2), strain Manhattan, Inactivated Leptospira canicola, Inactivated Leptospira icterohaemorrhagiae
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VIRBAC, Francija
|
| Date of authorisation/renewal: |
29-Jul-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (26-Jan-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (26-Jan-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (26-Jan-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/15/0057-01 |
|
1 |
Stikla flakons, 1 deva |
-
|
| V/MRP/15/0057-02 |
|
10 |
Stikla flakons, 1 deva |
-
|
| V/MRP/15/0057-03 |
|
25 |
Stikla flakons, 1 deva |
-
|
| V/MRP/15/0057-04 |
|
50 |
Stikla flakons, 1 deva |
-
|
| V/MRP/15/0057-05 |
|
100 |
Stikla flakons, 1 deva |
-
|
|
|
Calciveyxol 38
|
-
|
V/NRP/00/1250
|
Veyx-Pharma GmbH, Vācija
|
QA12AX
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for infusion
|
| International name (active substance): |
Calcii gluconas monohydricus, Magnesii chloridum hexahydricum, Acidum boricum
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
08-Jun-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 180520LI (18-May-2020)
|
| Labelling text: |
[DOCX] 180520M (18-May-2020)
|
| Summary of product characteristics: |
[DOCX] 180520ZA (18-May-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/00/1250-01 |
|
1 |
Plastmasas flakons, 500 ml |
-
|
| V/NRP/00/1250-02 |
|
12 |
Polietilēna flakons, 500 ml |
-
|
| V/NRP/00/1250-03 |
|
6 |
Polietilēna flakons, 500 ml |
-
|
|
|
Tenazym
|
-
|
V/NRP/99/1034
|
Veyx-Pharma GmbH, Vācija
|
QJ01RV01
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Trypsin,Neomycin sulphate,Papain,Chymotrypsin,Prednisolone acetate,Tetracycline hydrochloridum
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
07-Aug-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 09112018LI (09-Nov-2018)
|
| Labelling text: |
[PDF] 09112018M (09-Nov-2018)
|
| Summary of product characteristics: |
[PDF] 09112018ZA (09-Nov-2018)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/99/1034-01 |
|
10 |
Injektors, 10 ml |
-
|
|
|
Cefaximin-L
|
-
|
V/NRP/01/1376
|
Fatro S.p.A., Itālija
|
QJ51RD34
|
lactating cows
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1376-01 |
|
4 |
Injektors, 1 deva |
-
|
| V/NRP/01/1376-02 |
|
12 |
Injektors, 1 deva |
-
|
|
|
Opticlox eye ointment
|
167 mg/g
|
V/NRP/98/0813
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QS01AA90
|
cattle; sheep; horses; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
eye ointment
|
| International name (active substance): |
Cloxacillin benzathine
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
|
| Date of authorisation/renewal: |
22-Oct-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 310519LI (31-May-2019)
|
| Labelling text: |
[PDF] 310519M (31-May-2019)
|
| Summary of product characteristics: |
[PDF] 310519ZA (31-May-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/98/0813-01 |
167 mg/g |
4 |
Polipropilēna šļirce, 5 g |
-
|
|
|
Drycloxa-kel 685,13 mg/9 g
|
-
|
V/NRP/98/0717
|
Kela Laboratoria NV, Beļģija
|
QJ51CF02
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary suspension
|
| International name (active substance): |
Cloxacillin benzathine
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Kela Laboratoria NV, Beļģija
|
| Date of authorisation/renewal: |
15-Jul-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 040419LI (04-Apr-2019)
|
| Labelling text: |
[PDF] 040419M (04-Apr-2019)
|
| Summary of product characteristics: |
[PDF] 040419ZA (04-Apr-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/98/0717-01 |
|
20 |
Injektors, 1 deva |
-
|
|